Agoracom Blog

HPQ Silicon Edges Closer to Commercial Breakthrough in Multi-Billion Dollar Fumed Silica Market

Posted by Alavaro Coronel at 4:56 PM on Wednesday, August 20th, 2025

“When this is going to be validated, we will have changed the fumed silica industry. And where are we? We’re probably in the last in the last 100 meters of a 42 kilometers marathon”

Bernard Tourillon – CEO

HPQ Silicon

A GLOBAL MANUFACTURER COMES KNOCKING

When the world’s largest fumed silica producer requests samples from a small-cap innovator and provides positive feedback, investors should take note. HPQ Silicon is redefining the fumed silica industry with a cleaner, cheaper, and superior process. Its latest Phase 2 pilot tests have now scaled to unprecedented levels, producing material quantities well beyond earlier milestones.

WHY THIS MATTERS

Fumed silica is a multi-billion-dollar specialty material found in everyday products like cosmetics, toothpaste, and powdered foods. Today’s global supply is controlled by legacy chemical giants using costly, high-emission methods. HPQ’s disruptive process could reset the industry …  shifting power from entrenched producers to innovators.

SAMPLES ARRIVED AT WORLD’S LARGEST FUMED SILICA MANUFACTURER

Samples have been sent not only to the leading global fumed silica manufacturer for rapid validation and possibly as early as the end of this month.  Samples were also sent to an independent laboratory, ensuring HPQ has its own publishable data to share with investors and the world. Results are expected within weeks. If confirmed, HPQ Silicon could advance from pilot testing into commercial negotiations — positioning itself as the low-cost, clean-tech disruptor of a market that touches consumer staples worldwide.

OPERATIONAL BREAKTHROUGHS INCLUDE 50% FASTER START UP TIME

The pilot system is now producing 500 grams of fumed silica across multiple test cycles – a 16-fold increase in total material produced compared to earlier tests. This marks the first time HPQ has achieved quantities large enough for broad industry evaluation, a major step toward commercial viability.

HPQ’s proprietary Fumed Silica Reactor (FSR) also delivered strong process efficiency gains in Test #6:

  • REDUCED START-UP TIME: Optimal operating conditions reached 50% faster, cutting time and energy use.

  • INCREASED THROUGHPUT: Semi-continuous batches doubled, while total material output increased fivefold.

  • PROVEN SCALABILITY: Results reinforce confidence that HPQ’s process can transition from pilot scale to commercial operations.

Notably, HPQ has advanced through six consecutive tests without setbacks, each delivering measurable improvements.

THE CEO’S VIEW

“We’ve never produced this much material. The pilot plant is operating closer than ever to a commercial system, and every test shows positive progression,” said HPQ CEO Bernard Tourillon.

INVESTOR TAKEAWAY

HPQ’s steady march forward places it in the final stretch of a marathon that could change the structure of an entire industry. With global partners engaged and independent validation underway, the company is approaching a critical inflection point.

Renforth Resources Positioned at the Crossroads of Gold’s Bull Market and Critical Minerals Boom

Posted by Brittany McNabb at 4:20 PM on Monday, August 18th, 2025

Industry Outlook and Renforth Resources Trajectory

Gold’s three historic bull markets—1979, 2011, and today’s surge in 2025—showcase the evolving role of the metal as both hedge and store of value. Unlike past spikes driven by short-term crises, today’s rally is grounded in structural shifts: persistent fiscal deficits, reserve diversification, and renewed geopolitical uncertainty. With gold now trading above $3,300 per ounce, projects that are accessible, near-surface, and located in stable jurisdictions are drawing heightened attention.

 

Renforth Resources, advancing its Parbec Gold Deposit and Malartic Metals Package in Quebec, is strategically aligned with these macro dynamics. Its assets combine proven ounces of gold with critical mineral potential, positioning the company at the intersection of two growth narratives.

Voices of Authority

Industry observers note the distinct nature of today’s gold cycle. Unlike the parabolic surge of 1979 or the crisis-driven peak of 2011, the 2025 market has built strength over years of consolidation. Analysts highlight that central banks, institutional investors, and governments are underpinning the rally with sustained demand. This long-term structural bid provides a foundation for companies like Renforth that can deliver scalable resources in politically secure environments.

Renforth Resources Highlights

Renforth’s trajectory can be summarized through its milestones:

  • Flagship Asset: The Parbec Gold Deposit, with a confirmed 363,000 ounces, 87% contained in an optimized open-pit shell, directly adjacent to Agnico Eagle’s Canadian Malartic Mine. 
  • Location Advantage: All-season road and ramp access, as well as close proximity to processing infrastructure, reduce barriers to development. 
  • Advancement: Ongoing exploration at Parbec and critical metals properties, including Victoria, Lalonde, and Fouillac, supports both gold and multi-metal growth strategies. 
  • Scale Potential: The Malartic Metals Package spans ~300 km², already confirming nickel, copper, and zinc occurrences with road access. 
  • High-Value Strategy: With future bulk sampling permitted at Parbec and maiden resource modeling underway at Victoria, Renforth is creating optionality across both gold and critical minerals. 

Real-world Relevance

For businesses and investors, Renforth’s assets represent more than geological data. The company’s work translates into secure, strategically located resources that align with global priorities: gold as a hedge against fiscal uncertainty and critical minerals as building blocks of electrification and energy transition. The company’s ability to operate near established infrastructure in Quebec—one of the world’s most respected mining jurisdictions—adds further real-world value by minimizing logistical challenges and development risk.

Looking Ahead with Renforth Resources

The parallels between today’s gold market and prior bull cycles are clear, but the current cycle has broader foundations. As global institutions embed gold more deeply into their strategic reserves, and as demand for critical minerals accelerates, Renforth is positioned to benefit from both sides of this structural shift. The company’s near-term milestones—Parbec surface stripping, bulk sampling, and Victoria’s maiden resource estimate—reflect its focus on disciplined progress and operational leverage within the broader bull market.

Conclusion

Gold’s role in 2025 is larger and more enduring than in prior bull markets. Against this backdrop, Renforth Resources offers a rare combination: a growing gold deposit adjacent to a major producer and a critical metals package with regional scale. Together, these assets position the company as a relevant participant in Quebec’s mining future, aligned with the industry’s most powerful macro forces.

Source: https://x.com/KitcoNewsNOW/status/1957105617341997265

 

YOUR NEXT STEPS 

Visit $RFR HUB On AGORACOM:https://agoracom.com/ir/RenforthResources

Visit $RFR 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/RenforthResources/profile

Visit $RFR Official Verified Discussion Forum On AGORACOM:https://agoracom.com/ir/RenforthResources/forums/discussion

DISCLAIMER AND DISCLOSURE  

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

 

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

 

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

 

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit https://agoracom.com/terms-and-conditions

Quantum BioPharma’s Year of Execution: Clinical Momentum, Platform Progress, and a Stronger Balance Sheet

Posted by Brittany McNabb at 4:19 PM on Monday, August 18th, 2025

Advancing a Novel Approach to Multiple Sclerosis

Quantum BioPharma Ltd. (NASDAQ: QNTM; CSE: QNTM) is advancing therapies for challenging neurological and related conditions with a lead focus on multiple sclerosis (MS). Its flagship program, Lucid-MS (Lucid-21-302), is a patented, non-immunomodulatory compound designed to protect myelin—the insulating sheath around nerve fibers that is damaged in MS. Unlike many approved MS drugs that primarily suppress immune activity, Lucid-MS targets neuroprotection and myelin integrity, a differentiated strategy supported by preclinical data showing prevention of demyelination and reversal of paralysis.

From First-in-Human to Phase 2 Readiness

The program progressed through first-in-human testing with a Phase 1 multiple-ascending-dose (MAD) trial in healthy adults. The Clinical Study Report (CSR) concluded no safety or tolerability concerns following consecutive daily dosing—an essential milestone for opening the path to patient studies. In parallel, Quantum has signed an agreement with a leading CDMO to manufacture an oral formulation of Lucid-MS as the drug product for its planned Phase 2 clinical trial. The company has also begun preparing key components for an FDA Investigational New Drug (IND) application and submitted Lucid-MS to the UK’s ILAP Passport program, a pathway intended to accelerate access to promising medicines.

Measuring What Matters: Imaging Collaboration with MGH

A frequent obstacle in neuroprotective drug development is proving biological effect. To address this, Quantum is collaborating with Massachusetts General Hospital (MGH) scientists on imaging approaches to monitor myelin integrity. On August 5, 2025, MGH investigators published data in the European Journal of Nuclear Medicine and Molecular Imaging showing that PET tracer [18F]3F4AP exhibited strong brain-imaging properties and could detect differences across MS lesions not visible on conventional MRI. This tracer—developed at MGH and evaluated in healthy controls and people with MS—may serve as a biomarker to track demyelination and treatment response, potentially enhancing the precision of future Lucid-MS efficacy studies.

Pipeline Breadth: Phase 2 Ethics Approval for FSD202 in Australia

Beyond MS, Quantum’s pipeline includes FSD202, which targets nociplastic pain associated with idiopathic Mast Cell Activation Syndrome (MCAS)—a difficult-to-treat presentation of chronic, widespread musculoskeletal pain. In 2025, the company received Human Ethics Review Committee (HERC) approval in Australia for a Phase 2 randomized, double-blind, placebo-controlled trial designed to evaluate safety and efficacy in this population.

Spinout Progress Without Shareholder Dilution

Quantum also created value by spinning out the consumer OTC version of its alcohol-related wellness asset unbuzzd™ to Unbuzzd Wellness Inc. Quantum retains an equity stake (approximately 20% as of mid-2025) and royalty rights of 7% of sales until $250 million is reached, then 3% in perpetuity. In 2025, Unbuzzd launched a Reg D 506(c) capital raise of up to US$5 million to fund growth and a potential go-public path. The company noted this financing does not dilute Quantum BioPharma shareholders. Unbuzzd’s U.S. commercialization continues, with additional regulatory steps underway for Canada.

Strengthening the Balance Sheet

Operational progress has been matched by financial housekeeping. For the quarter ended June 30, 2025, Quantum reported:

  • Current assets of US$10.3 million (up from US$9.9 million at March 31, 2025) and total assets of US$15.3 million (up from US$14.9 million).
  • All debentures converted to equity, removing that liability; previously recorded warrant liability (a non-cash item) was eliminated as all outstanding warrants were exercised by the date of filing.
  • Receipt of a US$2.35 million settlement related to prior management litigation; the Sports Coat litigation loan was fully repaid with full release received.
  • Treasury diversification that includes approximately US$5.5 million of Bitcoin and other cryptocurrencies, with over US$500,000 in realized and unrealized gains as of filing.
  • Management indicated sufficient cash on hand to maintain basic operations beyond March 2027.

During Q2 2025, the share price rose from US$7.71 (March 31) to US$20.25 (June 30), reflecting a period of notable execution across clinical, operational, and financial fronts.

Outlook

Quantum BioPharma enters the next phase with a de-risked safety profile for its lead MS candidate, manufacturing in place for an oral Phase 2 program, and an imaging collaboration that could sharpen efficacy readouts. The company is also advancing FSD202 into a Phase 2 study in Australia and maintaining non-dilutive exposure to a commercializing consumer asset via Unbuzzd. Combined with a cleaner balance sheet and extended cash runway, the setup positions Quantum to pursue upcoming clinical and corporate milestones with focus and flexibility.

All program descriptions reflect company disclosures, published study findings from MGH collaborators, and the most recent financial updates provided by Quantum BioPharma in 2025.

 

Visit $QNTM HUB On AGORACOM : https://agoracom.com/ir/Quantumbiopharma

Visit $QNTM 5 Minute Research Profile On AGORACOM: https://agoracom.com/ir/Quantumbiopharma/profile

Visit $QNTM Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/Quantumbiopharma/forums/discussion

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post. You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000. 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

Draganfly Q2 Revenue Jumps 22% to $2.12M as Cash Reserves Surge to $22.6M

Posted by Brittany McNabb at 5:26 PM on Friday, August 15th, 2025

UAV maker posts double-digit revenue growth as it lands defense orders, a Fortune 50 telecom deal, and a Pentagon showcase slot

Introduction

Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) reported second-quarter revenue growth and a string of operational wins that deepen its footprint in defense, public safety, and emergency infrastructure. Product sales rose 37% year over year in Q2 2025, helping lift total revenue 22% as the company advanced deliveries to U.S. defense programs, secured a Fortune 50 telecommunications customer for disaster recovery, and demonstrated an integrated tactical system at an invite-only Pentagon event. 

Background and Context

Founded more than two decades ago, Draganfly is best known for building modular unmanned aerial platforms used in time-sensitive missions. The company’s heritage includes one of the most widely cited early rescues by a public-service drone, when Canadian authorities used a Draganflyer to help locate an injured driver in 2013—an episode frequently credited as a first for life-saving drone use. That real-world orientation continues to shape the firm’s product roadmap and go-to-market focus. 

Q2 by the Numbers

In the quarter ended June 30, 2025, Draganfly posted revenue of $2.12 million (+22.1% YoY) and product sales of $1.90 million (+37.1% YoY). Gross profit was $505,000, with a gross margin of 23.9% versus 26.6% a year ago, a decrease the company attributed to sales mix. Cash and equivalents stood at $22.57 million at quarter-end, up from $6.25 million on December 31, 2024. The company reported a comprehensive loss of $4.75 million, including non-cash items. 

The stronger cash position reflects a series of financings, including a $25 million registered direct offering that closed in July 2025. 

What’s Driving the Pipeline

Defense traction. In July, a major branch of the U.S. Department of Defense selected Draganfly’s Commander3 XL for advanced operational initiatives, and the company separately announced a strategic military order for the platform—adding validation in intelligence, surveillance and reconnaissance (ISR) and related missions. In June, Draganfly began delivering its Flex FPV systems under an order from a major U.S. prime contractor. 

Pentagon demonstration. On August 5, Draganfly showcased an integrated tactical strike system—developed with MMS Products’ “Mjolnir” modular munition—at the Pentagon’s Low-Cost Uncrewed Combat Attack Systems event, highlighting modular payload integration and ISR-to-strike workflows. 

Disaster recovery and telecom resilience. After extensive testing with Infinity Communications, a Fortune 50 telecom purchased multiple Draganfly Heavy Lift drones to move supplies and restore communications in storm-damaged or inaccessible areas—an example of how UAV logistics are being embedded in business continuity plans. 

Humanitarian demining. In April, SafeLane Global named Draganfly its preferred global provider of landmine-mapping drones and aerial survey services in a multi-year agreement, with the first Ukraine aerial-survey contract underway—expanding the firm’s role in humanitarian operations. 

Why It Matters

Together, these developments put Draganfly at the nexus of three durable demand drivers: defense modernization, critical-infrastructure resilience, and humanitarian/ public-safety missions. Defense orders and Pentagon-level demonstrations can translate into longer-term programs if performance milestones are met. Commercial adoption by a Fortune 50 telecom underscores use cases beyond defense, where drones can shorten recovery time and improve safety after disasters. Humanitarian contracts broaden the addressable market while reinforcing the brand’s mission-driven identity. 

Expert and Company Views

Company leaders have framed recent wins as proof points for a modular, mission-ready approach built around North American, NDAA-compliant systems. In the Pentagon release, Draganfly emphasized that the LUCAS demonstration validated its integration and autonomy work in contested environments; the SafeLane agreement similarly positions the company as a specialist supplier in complex, high-risk settings. 

Challenges and Considerations

Despite top-line and product-sales growth, Draganfly remains loss-making as it invests in personnel, R&D, and market expansion; margins also move with product mix, which can pressure profitability in any given quarter. Execution risk is inherent in defense and public-sector sales cycles, where revenue can be lumpy and contingent on trials, security reviews, and budget timing. The company’s bolstered cash balance provides runway to support production scaling and program deliveries, but sustained growth will depend on converting pilots and initial orders into recurring or multi-year awards. 

Bottom Line

Q2 2025 offered a clear snapshot of Draganfly’s strategy in motion: expand in defense with validated platforms, extend into enterprise resilience with heavy-lift logistics, and apply the same technology stack to humanitarian missions. With fresh capital, a fuller order book, and marquee demonstrations, the company is positioned to compete for larger programs as organizations look to unmanned systems for faster response, better data, and safer operations.

YOUR NEXT STEPS

 

Visit $DPRO HUB On AGORACOM:http:// https://agoracom.com/ir/Draganfly 

Visit $DPRO 5 Minute Research Profile On AGORACOM:http:// https://agoracom.com/ir/Draganfly/profile

Visit $DPRO Official Verified Discussion Forum On AGORACOM:http:// https://agoracom.com/ir/Draganfly/forums/discussion

 Watch $DPRO Videos On AGORACOM YouTube Channel:

https://www.youtube.com/playlist?list=PLfL457LW0vdIXvNVrqwDRK0Pe8i_bAUzr

 

DISCLAIMER AND DISCLOSURE 

 

 This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

 AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

 

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

 

NO INVESTMENT ADVICE

 

 This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

 

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit http://  https://agoracom.com/terms-and-conditions

 

Lancaster Resources Launches Field Work at Lake Cargelligo Gold Project — Described by CEO as a ‘Potential Company-Maker’

Posted by Brittany McNabb at 5:25 PM on Friday, August 15th, 2025

Junior explorer advances a multi-asset portfolio while launching field work for its maiden NI 43-101 at Lake Cargelligo.

Vancouver — Lancaster Resources Inc. (CSE: LCR | OTC: LANRF | FRA: 6UF0) has begun desk and field work at its 100%-owned Lake Cargelligo Gold Project in New South Wales, Australia—an early but important step toward completing the company’s first National Instrument 43-101 technical report on the asset. The program marks tangible progress following a year of portfolio building across gold, uranium and polymetallic targets in Canada and Australia.

The initiative matters for two reasons. First, Lake Cargelligo sits in the prolific Lachlan Fold Belt and covers 28,768 hectares with multiple historical gold and silver occurrences. Second, a maiden NI 43-101 establishes a standardized technical baseline for future work, helping the company prioritize targets and sequence capital.

Background and Context

Lancaster is assembling district-scale exploration positions in mining-friendly jurisdictions. Its portfolio includes the Lake Cargelligo Gold Project in Australia; the Piney Lake gold property in Saskatchewan; the Catley Lake and Centennial East uranium projects in Saskatchewan’s Athabasca Basin; and Quebec’s Lac Iris polymetallic project in the James Bay region, where the company also holds an option on the Trans-Taiga property. In Australia, Lancaster operates through a wholly owned subsidiary created to advance exploration and development.

At Lake Cargelligo, historical work reported surface rock-chip results up to 204 grams per tonne (g/t) gold and 273 g/t silver, and channel sampling intercepts up to 16 meters at 5.83 g/t gold and 7.20 g/t silver. These figures, disclosed by the company, are historical and have not yet been verified by a Qualified Person under NI 43-101, but they frame the initial areas of interest for the 2025 work program.

Key Highlights and Advantages

  • Field work underway: Reconnaissance geological mapping and rock-chip sampling have commenced to refine targets for a focused drill program. 
  • Maiden NI 43-101 in process: Lancaster anticipates completing the report by August 31, 2025, providing a structured technical foundation for the project. 
  • District scale: Lake Cargelligo covers 28,768 hectares in the Lachlan Fold Belt, a region known for significant gold endowment. 
  • Portfolio breadth: Active positions in gold (Australia and Saskatchewan), uranium (Athabasca Basin), and polymetallic targets (James Bay) offer multiple exploration pathways. 

What differentiates the current phase is movement from claim consolidation to on-the-ground work—paired with a clear reporting milestone and a stated plan to progress toward drill targeting.

Potential Impact and Significance

For the company, the field program at Lake Cargelligo is a practical inflection point. A completed NI 43-101 should help prioritize targets, guide future budgets and timelines, and provide a consistent technical reference for subsequent results. Portfolio breadth—across gold, uranium and polymetallics—also allows Lancaster to pursue opportunities that align with commodity cycles while concentrating near-term activity where access, permitting and historical data support a faster start.

Expert Opinions and Analysis

“Commencing field work at Lake Cargelligo represents a pivotal moment for Lancaster,” said Andrew Watson, P.Eng., President and CEO. “Our maiden NI 43-101 Technical Report for Lake Cargelligo will be the foundation for systematic exploration, guiding our strategy toward resource definition and value creation for our shareholders.” Watson is the company’s Qualified Person as defined under NI 43-101 and has reviewed and approved the scientific and technical information in the news release.

Separately, Lancaster confirmed it has engaged Ora IR Services Inc. to support investor relations, including customer service management and communications. The agreement includes the grant of 1.8 million stock options exercisable at $0.10 per share and monthly cash compensation between $10,000 and $20,000, with Ora’s principal, Geoff Skinner, acting as consultant.

Challenges and Considerations

As an early-stage explorer, Lancaster faces common risks: historical results require modern verification; timelines can be affected by permitting, access, and seasonal field conditions; and mineralization on adjacent or nearby properties is not necessarily indicative of mineralization on Lancaster’s ground. The company notes that historical results cited at Lake Cargelligo have not been verified by a Qualified Person. In Quebec, the Lac Iris claims remain “Being Processed” pending confirmation from SIGEOM and the provincial ministry.

Mitigation steps include sequencing work toward a formal NI 43-101, focusing initial efforts on mapping and sampling to de-risk drill targeting, and coordinating programs across projects (including planned hyperspectral analysis in James Bay) to improve efficiency.

Conclusion

Lancaster Resources is moving from portfolio assembly to execution. With field work underway at Lake Cargelligo and a clear target date for its maiden NI 43-101, the company is laying the technical groundwork needed to advance a district-scale gold asset—all while maintaining exposure to uranium and polymetallic opportunities in Canada. For a junior explorer, that combination of focus on a lead project and optionality across the broader portfolio may prove decisive as 2025 unfolds.

YOUR NEXT STEPS

Visit $LCR HUB On AGORACOM:http:// https://agoracom.com/ir/Lancasterresources

Visit $LCR 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/Lancasterresources/profile

Visit $LCR Official Verified Discussion Forum On AGORACOM:

https://agoracom.com/ir/Lancasterresources/forums/discussion

 

DISCLAIMER AND DISCLOSURE 

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

 

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.

 

In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.  

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

HPQ Silicon Fast-Tracks Breakthrough Battery Tech From Lab to Production

Posted by Alavaro Coronel at 10:27 AM on Friday, August 15th, 2025

FROM LAB SUCCESS TO MARKET-READY PRODUCT

HPQ Silicon $HPQ / $HPQFF has moved from prototype to production in record time, delivering its first commercial-scale silicon-anode battery cells — a milestone that positions the company at the forefront of a ~$16B market for mobility, electronics, and energy storage.

The company began manufacturing HPQ ENDURA+ 18650 and 21700 cells, delivering 4,000 mAh and 6,000 mAh capacity with lifespans approaching 1,000 cycles — performance that CEO Bernard Tourillon says is “unheard of” in commercially sized batteries. Independent third-party validation confirmed the results first achieved at the lab scale are now replicable in industrial production.

GLOBAL INTEREST AND STRATEGIC POSITIONING

  • Inquiries from Asia, Europe, and North America including power tool, e-bike, drone, and military suppliers
  • Partnership discussions underway with industry leaders, including graphite producers seeking to enhance their products with HPQ’s silicon-anode material
  • Ability to integrate into existing battery manufacturing lines without costly retooling

“We continue to receive inquiries from global potential customers and are engaging in technical discussions with leading industry players… With production now underway, we anticipate an acceleration of partnership opportunities as soon as we start delivering.” — Bernard Tourillon, CEO, HPQ Silicon

SCALABLE GROWTH POTENTIAL

The company estimates that a 50-ton annual production facility for its proprietary silicon-anode material — an investment of $5–$7 million — could supply up to 25–30 million batteries. With North American exclusivity via its partnership with Novacium, HPQ is positioned to scale quickly as orders come in.

WHY INVESTORS ARE WATCHING

HPQ has compressed the typical multi-year commercialization cycle into under 18 months, leapfrogging the pilot phase and moving directly to commercial manufacturing. By demonstrating its technology in market-ready cells, HPQ aims to convert competitors into customers, accelerate adoption, and secure a foothold in high-value battery segments.

Bottom line: HPQ Silicon is no longer just developing — it’s delivering. With global attention, validated performance, and a clear path to scale, the company is poised to become a key supplier in the next generation of high-performance batteries.

Your Gateway to Tokenized Small Cap Financing — Live August 12

Posted by AGORACOM-JC at 12:01 PM on Thursday, August 7th, 2025

The countdown is on. In just days, AGORACOM will unveil a bold new era for small cap companies — introducing tokenized capital raises, 24/7 global investor access, and technology-driven solutions to legacy market limitations.

AGORACOM Tokenized Financing Webcast

Tuesday, August 12 • 4:15 PM ET

RSVP: https://lu.ma/AgoracomRWAwebcast2025

Already registered? No action required.

Momentum is building. On July 31, 2025, the U.S. Securities and Exchange Commission announced Project Crypto — a landmark initiative to explore how blockchain and token-based assets could be integrated into U.S. capital markets.

AGORACOM has spent the past two years preparing for this moment — working with world-class partners in Dubai to develop a next-generation financing infrastructure built for speed, scalability, and compliance.

During the webcast, you’ll discover:

✅ How tokenized capital raises using real-world asset infrastructure function

✅ The mechanics behind 24/7 global access to compliant, asset-backed tokens

✅ How AGORACOM’s platform is designed to help small caps participate in this emerging landscape

The next evolution of capital markets is underway — and the opportunity to participate starts now.

Reserve your spot today

Exclusive Look: Our Dubai RWA Partnership Explained – Register Now

Posted by AGORACOM-JC at 12:01 PM on Tuesday, August 5th, 2025

How Tokenization Could Reshape Small Cap Financing – Join Our Webcast

Posted by AGORACOM-JC at 10:30 AM on Tuesday, July 29th, 2025

Renforth Resources Expands Surface Mineralization at Parbec, Host to 363,000 oz Gold

Posted by Brittany McNabb at 12:13 PM on Monday, July 28th, 2025

Renforth Resources Inc. (CSE: RFR | OTCQB: RFHRF | FSE: 9RR) has provided an update on surface exploration activities at its Parbec Gold Deposit, located within Quebec’s Abitibi Greenstone Belt. This region has historically produced more than 200 million ounces of gold and remains an area of active exploration and mining.

The Parbec property is approximately 4 km from Agnico Eagle’s Canadian Malartic Mine, one of Canada’s largest operating open-pit gold mines. The deposit has existing road access and ramp infrastructure from prior exploration programs.

Current Mineral Resource Estimate

The Parbec property hosts a 2025 mineral resource estimate prepared in accordance with NI 43-101, reporting an inferred resource of approximately 363,000 ounces of gold. Ongoing work programs focus on improving geological understanding, assessing grade continuity, and evaluating potential development scenarios.

Surface Sampling Results

The company recently completed surface channel sampling at the Diorite Splay structure on the Parbec property. Results included 12 metres grading 1.43 g/t gold, extending a previously identified mineralized channel first sampled in 2017, which returned 1.55 g/t gold over 9.0 metres. These results will assist in refining exploration targets and guiding future work programs.

Additional Sampling in Ramp Portal Area

Renforth also reported sampling in the Ramp Portal area, which returned additional gold values within Pontiac sediment-hosted mineralization intruded by felsic dykes. These results help define mineralized zones along the Cadillac-Larder Lake Fault corridor, a regional structure known to host multiple gold deposits.

Next Steps

Renforth plans to continue surface sampling and geological modeling to refine its understanding of the Parbec deposit and evaluate cost-effective exploration techniques. 

YOUR NEXT STEPS 

Visit $RFR HUB On AGORACOM:https://agoracom.com/ir/RenforthResources

Visit $RFR 5 Minute Research Profile On AGORACOM:https://agoracom.com/ir/RenforthResources/profile

Visit $RFR Official Verified Discussion Forum On AGORACOM:https://agoracom.com/ir/RenforthResources/forums/discussion

DISCLAIMER AND DISCLOSURE  

This record is published on behalf of the featured company or companies mentioned (Collectively “Clients”), which are paid clients of Agora Internet Relations Corp or AGORACOM Investor Relations Corp. (Collectively “AGORACOM”)

 

AGORACOM.com is a platform. AGORACOM is an online marketing agency that is compensated by public companies to provide online marketing, branding and awareness through Advertising in the form of content on AGORACOM.com, its related websites (smallcapepicenter.com; smallcappodcast.com; smallcapagora.com) and all of their social media sites (Collectively “AGORACOM Network”) .  As such please assume any of the companies mentioned above have paid for the creation, publication and dissemination of this article / post.

You understand that AGORACOM receives either monetary or securities compensation for our services, including creating, publishing and distributing content on behalf of Clients, which includes but is not limited to articles, press releases, videos, interview transcripts, industry bulletins, reports, GIFs, JPEGs, (Collectively “Records”) and other records by or on behalf of clients. Although AGORACOM compensation is not tied to the sale or appreciation of any securities, we stand to benefit from any volume or stock appreciation of our Clients.  In exchange for publishing services rendered by AGORACOM on behalf of Clients, AGORACOM receives annual cash and/or securities compensation of typically up to $125,000.

 

Facts relied upon by AGORACOM are generally provided by clients or gathered by AGORACOM from other public sources including press releases, SEDAR and/or EDGAR filings, website, powerpoint presentations.  These facts may be in error and if so, Records created by AGORACOM may be materially different. In our video interviews or video content, opinions are those of our guests or interviewees and do not necessarily reflect the opinion of AGORACOM.

From time to time, reference may be made in our marketing materials to prior Records we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

 

NO INVESTMENT ADVICE

This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell products or securities.

You understand and agree that no content in this record or published by AGORACOM constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person and that no such content is tailored to any specific person’s needs. We will never advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

 

Neither the writer of this record nor AGORACOM is an investment advisor.  Both are neither licensed to provide nor are making any buy or sell recommendations. For more information about this or any other company, please review their public documents to conduct your own due diligence.

 

If you have any questions, please direct them to [email protected] 

For our full website disclaimer, please visit https://agoracom.com/terms-and-conditions